NCT04183114 Immunogenicity & Safety of Bio Farma's Measles-Rubella (MR) Vaccine in Indonesian Infants (Bridging Study) Status COMPLETED Phase PHASE2/PHASE3
NCT04177485 Evaluating a Caregiver SMS Reminder Intervention to Reduce Immunization Drop-out in Arua, Uganda Status COMPLETED Phase NA
NCT04013516 Measles Vaccination Cash Incentives Experimental Evidence From Nigeria Status COMPLETED Phase NA
NCT03870061 Evaluation of an Infant Immunization Encouragement Program in Nigeria Status COMPLETED Phase NA
NCT03330171 Safety and Immunogenicity of Measles Vaccine, Varicella Vaccine and Hepatitis-A Vaccine Status UNKNOWN Phase PHASE4
NCT03160820 Study on Immunization Schedule of Beijing Tiantan Biological's Measles-mumps-rubella(MMR) Vaccine Status COMPLETED Phase PHASE4
NCT03148990 Study to Evaluate the Immunogenicity, Reatogenicity and Safety of Double Viral Vaccine (MR) for Measles and Rubella Status COMPLETED Phase PHASE2/PHASE3
NCT03071575 Measles-Rubella Vaccine Immunogenicity at 6 and 9 Months of Age Status COMPLETED Phase PHASE4
NCT02904642 Mobile and Scalable Innovations for Measles Immunization: a Randomized Controlled Trial Status COMPLETED Phase NA
NCT02880865 Immunogenicity and Safety of Japanese Encephalitis Vaccine When Given With Measles-Mumps-Rubella (MMR) Vaccine Status COMPLETED Phase PHASE4
NCT02712203 MMR and MMRV Vaccines: Effect of Age at First Dose on Safety and Immunogenicity of the Measles Component. Status UNKNOWN Phase N/A
NCT02662595 mHealth to Increase Measles Immunization - a Randomized Controlled Trial in Guinea-Bissau Status UNKNOWN Phase NA
NCT02643433 Immunogenicity of Co-administration of Measles and Japanese Encephalitis Vaccines Status COMPLETED Phase PHASE4
NCT02325310 Search for the Measles Vaccine Virus Excretion in Breast Milk of Breastfeeding Women After Postpartum Vaccination With MMR Status COMPLETED Phase PHASE4
NCT02196285 Study to Evaluate Safety and Imunogenicity of Double Viral Vaccine (MR) for Measles and Rubella Status COMPLETED Phase PHASE1
NCT02058927 Immune Reconstitution to Measles Virus of HIV Infected Children in Zambia Status COMPLETED Phase N/A
NCT02058563 Immunogenicity and Safety of GSK Biologicals' Combined Measles-mumps-rubella Vaccine in Volunteers, Seven Years of Age and Older Status COMPLETED Phase PHASE3
NCT01991899 Study of Immunogenicity, Reactogenicity and Safety of the Combined Measles, Mumps and Rubella Vaccine Produced by Bio-Manguinhos/Fiocruz in Children 12-15 Months of Age, Followed by Tetraviral Vaccine in Children 15-18 Months. Status COMPLETED Phase PHASE3
NCT01878435 Randomized Controlled Trial of the Impact of Mobile Phone Delivered Reminders and Travel Subsidies to Improve Childhood Immunization Coverage Rates and Timeliness in Western Kenya Status COMPLETED Phase NA